Medicines and Healthcare products Regulatory Agency
Certificate of GMP Compliance Of A Manufacturer(1),(2)
Regulation 331A of The Human Medicines Regulations 2012 (SI 2012/1916)
The competent authority of United Kingdom confirms the following :From the knowledge gained during inspection of this manufacturer, the latest of which was conducted on 17/07/2013, it is considered that it complies with:
This certificate reflects the status of the manufacturing site at the time of the inspection noted above and should not be relied upon to reflect the compliance status if more than three years have elapsed since the date of that inspection. However, this period of validity may be reduced or extended using regulatory risk management principles by an entry in the Restrictions or Clarifying remarks field. This certificate is valid only when presented with all pages and both Parts 1 and 2. The authenticity of this certificate may be verified in MHRA-GMDP. If it does not appear, please contact the issuing authority.
- (1) Guidance on the interpretation of this template can be found in the Help menu of MHRA-GMDP database.
- (2) These requirements fulfil the GMP recommendations of WHO.
Manufacture of active substance. Names of substances subject to inspection:
- [1000018046] ACTIVE SUBSTANCES FOR CLINICAL TRIALS
| 3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES | |
| ACTIVE SUBSTANCES FOR CLINICAL TRIALS | |
| 3.1 | Manufacture of Active Substance by Chemical Synthesis |
| 3.1.1 Manufacture Of Active Substance Intermediates | |
| 3.1.2 Manufacture Of Crude Active Substance | |
| 3.1.3 Salt Formation/Purification steps (eg. Crystallisation) Synthetically manufactured peptides are purified. | |
| 3.3 | Manufacture of Active Substance using Biological Processes |
| 3.3.3 Isolation / Purification | |
| 3.5 | General Finishing Steps |
| 3.5.2 Primary Packaging | |
| 3.6 | Quality Control Testing |
| 3.6.1 Physical / Chemical testing | |
Any restrictions related to the scope of this certificate:
| Building | Room | Line/equipment | QC Testing | Products |
|---|---|---|---|---|
| For testing of materials, intermediates and finished products associated with manufacture on site | Synthesis of APIs and peptides up to kilo scale, also for use in clinical trials |
| 16/09/2013 | Name and signature of the authorised person of the Competent Authority of United Kingdom |
| Confidential | |
| Medicines and Healthcare products Regulatory Agency | |
| Tel : Confidential |